Roche sues Mylan over Herceptin biosimilar

07-02-2014

Roche sues Mylan over Herceptin biosimilar

Photo: Courtesy of Roche.com

Roche’s Indian subsidiary has sued Mylan and Bangalore-based pharmaceutical company Biocon at the Delhi High Court, for launching a biosimilar of its breast cancer drug Herceptin (trastuzumab).


Roche, Mylan, Biocon, Herceptin, Delhi High Court

LSIPR